Skip to main content

Table 9 The bioactivities (pIC50), predicted (pIC50) and residual of the model

From: QSAR, molecular docking studies, ligand-based design and pharmacokinetic analysis on Maternal Embryonic Leucine Zipper Kinase (MELK) inhibitors as potential anti-triple-negative breast cancer (MDA-MB-231 cell line) drug compounds

Structure

Bioactivities(pIC50)

Predicted(pIC50)

Residual

1*

5.8697

5.8575

0.0122

2

6.1308

6.0889

0.0419

3

5.7447

5.7767

− 0.0310

4*

5.8477

5.8647

− 0.0170

5*

5.8761

5.8413

0.0348

6

5.7471

5.8016

− 0.0544

7

6.3372

5.9952

0.3421

8*

6.4685

6.0575

0.4110

9

6.0809

6.1495

− 0.0686

10

5.7610

5.6714

0.0906

11

5.7496

5.8640

− 0.1144

12

5.7852

5.8690

− 0.0848

13

5.9666

5.9944

− 0.0278

14

5.7352

5.7595

− 0.0243

15

5.5986

5.4421

0.1565

16*

5.8794

5.6169

0.2625

17

5.9136

5.8413

0.0723

18

5.9914

5.8049

0.1865

19

5.6430

5.7113

− 0.0674

20*

5.8761

5.8355

0.0406

21

5.7610

5.8648

− 0.1020

22

5.8013

5.8464

− 0.0450

23

5.9393

5.7953

0.1430

24

5.7144

5.7631

− 0.0487

25*

5.7447

5.8080

− 0.0633

26*

5.7235

5.6361

0.0875

27

5.6968

5.8680

− 0.1722

28

5.6478

5.6913

− 0.0435

29

5.7447

5.9183

− 0.1736

30

5.6402

5.4665

0.1737

31

5.4855

5.5797

− 0.0943

32

5.5544

5.5653

− 0.0109

33

5.8297

5.8392

− 0.0095

34

5.7447

5.9110

− 0.1672

35*

5.7595

6.1619

− 0.4025

36

6.2596

6.1104

0.1492

37

6.5850

6.4285

0.1566

38

6.6021

6.2714

0.3307

39

5.7090

5.8368

− 0.1268

40

5.6946

5.7957

− 0.1011

41*

5.7520

6.0801

− 0.3281

42*

5.9914

5.9095

0.0819

43*

5.9626

6.3221

− 0.3595

44

6.0223

5.8656

0.1568

45

5.7986

5.7778

0.0208

46

5.7986

5.8829

− 0.0843

47

5.8239

5.8352

− 0.0113

48*

5.6968

5.6558

0.0410

49

5.7033

5.6116

0.0917

50

5.6946

5.6849

0.0098

51

5.6968

5.7200

− 0.0242

52*

5.5302

5.7680

− 0.2388

53*

5.6003

5.5391

0.0612

54

5.7282

5.6032

0.1249

55

5.7282

5.6806

0.0476

56

5.7545

5.8740

− 0.1196

57*

5.6478

5.5005

0.1473

58*

5.1232

5.3008

− 0.1776

59

5.6289

5.7336

− 0.1046

60*

5.4498

5.5363

− 0.0865

61

5.6383

5.6725

− 0.0342

  1. The compounds with (*) are the test set, while the compounds without (*) are the train set